| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.00B | +2.7% |
| Cost of Revenue | $622.3M | -2.6% |
| Gross Profit | $381.5M | +12.8% |
| R&D Expense | $117.4M | +6.9% |
| SG&A Expense | $143.1M | +15.1% |
| Operating Income | $13.1M | +106.3% |
| Pre-tax Income | $45.1M | +127.9% |
| Income Tax | $14.0M | -28.7% |
| Net Income | $31.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $403.8M | -34.9% |
| Short-term Investments | $435.5M | +40.4% |
| Accounts Receivable | $181.7M | +6.2% |
| Inventory | $313.4M | +10.1% |
| Current Assets | $1.42B | -0.5% |
| Total Assets | $2.42B | +5.9% |
| Current Liabilities | $234.0M | +14.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $75.3M | -69.6% |
| Capital Expenditures | $78.8M | -20.0% |
| Investing Cash Flow | -$265.2M | -227.1% |
| Financing Cash Flow | -$54.2M | +84.0% |
| Free Cash Flow | -$3.5M | -102.3% |
| +117.1% |
| EPS (Basic) | $0.73 | +117.8% |
| EPS (Diluted) | $0.73 | +117.8% |
| Total Liabilities |
| $296.1M |
| +11.8% |
| Stockholders' Equity | $2.13B | +5.1% |